
Yaron Daniely Hopes For The Best As Alcobra Ltd (NASDAQ:ADHD) Enrolls First Patient
Boston, MA 08/20/2014 (wallstreetpr) – Alcobra Ltd (NASDAQ:ADHD), an emerging drugs company with more than $296 million in market cap, announced first successful enrollment of













